Intermagnetics to Discuss Growth Strategy, Outlook at the UBS Global Life Sciences Conference

LATHAM, N.Y., Sept. 22  /PRNewswire-FirstCall/ -- Intermagnetics General Corporation (NASDAQ:IMGC) announced today that management will discuss the company's growth strategy and outlook during the UBS Global Life Sciences Conference.

The company's scheduled presentation will be given by Glenn H. Epstein, CEO:

Monday, September 26th at 11:00 am EDT in Ballroom A at the Grand Hyatt New York Hotel.

The presentation will be available live and archived on Intermagnetics' website at http://www.intermagnetics.com/ under the News and Events/Calendar section.

Intermagnetics (http://www.intermagnetics.com/) draws on the financial strength, operational excellence and technical leadership in the market of Magnetic Resonance Imaging (MRI), as well as its expanding businesses within Medical Devices that encompass Invivo Diagnostic Imaging (focusing on MRI components & imaging sub-systems) and Invivo Patient Care (focusing on monitoring & other patient care devices). Intermagnetics is also a prominent participant in superconducting applications for Energy Technology. The company has a more than 30-year history as a successful developer, manufacturer and marketer of superconducting materials, high-field magnets, medical systems & components and other specialized high-value added devices. 

DATASOURCE: Intermagnetics General Corporation



CONTACT:  Cathy Yudzevich, IR Manager, Intermagnetics General

Corporation, [phone]



Web site:  http://www.intermagnetics.com/ 

Copyright